QP 27 - Getting SMART About Ablative Radiation Therapy in Pancreaticobiliary Cancer and Liver Metastases

Presentations

• 05:00pm - 05:05pm ET

  Introductions

  Speaker: Aisling Barry, MBBS, MSc, FFR RCSI, FRCPC - University College Cork, Cork
• 05:05pm - 05:10pm ET

  Excellent 2- and 3-Year OS after Ablative MRgRT for Localized Pancreatic Cancer without Surgery

  Speaker: Marsha Reyngold, MD, PhD - Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York
• 05:10pm - 05:15pm ET

  Stereotactic Magnetic Resonance (MR)-Guided Adaptive Radiotherapy (SMART) for Liver Metastases near Critical Organs at Risk: A Phase I Trial and Supplemental Cohort for Feasibility and Safety

  Speaker: Nadia Saeed, MD - Harvard Radiation Oncology Program, Boston
• 05:15pm - 05:20pm ET

  Fourteen-Year Single-Institution Experience Using MRI-Guided SBRT on an Orthotopic Liver Transplantation Protocol for Unresectable Cholangiocarcinoma

  Speaker: Trudy Wu, MD, BS - University of California Los Angeles, Los Angeles
• 05:20pm - 05:25pm ET

  Heterogeneity within Oligometastatic Pancreatic Cancer: Impact of Metastatic Burden on Outcomes after Metastasis-Directed Therapy

  Speaker: Emerson Lee, MD - Mass General Brigham, Somerville
• 05:25pm - 05:30pm ET

  Neoadjuvant Therapy with Radiation for Locally Advanced Pancreatic Cancer: Outcomes from a Large Single-Institution Cohort

  Speaker: Hannah Roberts, MD - Harvard Radiation Oncology Program, Boston
• 05:30pm - 05:35pm ET

  Safety and Tolerability of Dose-Escalated, Hypofractionated Radiation Therapy in Combination with Losartan for Locally Advanced Pancreatic Cancer, a Phase I Prospective Clinical Trial

  Speaker: Shane Lloyd, MD - University of Utah, Salt Lake City
• 05:35pm - 05:55pm ET

  Questions & Answers

  Speaker: Andrzej Wojcieszynski, MD - Denver Oncology, Denver
• 05:55pm - 06:00pm ET

  Closing

  Speaker: Aisling Barry, MBBS, MSc, FFR RCSI, FRCPC - University College Cork, Cork